Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Pfizer to drop $74M for COVID cough-screening smartphone app developer
Fierce Biotech
Mon, 04/11/22 - 07:35 pm
Pfizer
ResApp Health
COVID-19
Medtech
diagnostics
M&A
mobile apps
High-flying Pfizer may disappoint on Comirnaty and Paxlovid sales in Q1, analyst warns
Fierce Pharma
Mon, 04/11/22 - 07:32 pm
Pfizer
BioNTech
Paxlovid
Comirnaty
vaccines
COVID-19
earnings
Pfizer rolls out voluntary retirement scheme in India as it dives deeper into digital
Fierce Pharma
Thu, 04/7/22 - 05:54 pm
Pfizer
India
digital pharma
voluntary retirement scheme
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
Fierce Biotech
Thu, 04/7/22 - 10:29 am
Pfizer
RSV
M&A
ReViral
A bill from Pfizer may eat up half of potential COVID-19 fund
Beckers Hospital Review
Wed, 04/6/22 - 07:40 pm
Pfizer
COVID-19
Senate
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Wed, 04/6/22 - 11:52 am
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Ukraine war, China's COVID lockdown and more could weigh on J&J's early-year performance—and it may not be alone: analysts
Fierce Pharma
Tue, 04/5/22 - 11:53 am
JNJ
pandemic
Ukraine
COVID-19
Merck
Pfizer
Eli Lilly
Pfizer asks hourly staffers to return overpayments in aftermath of vendor's cyberattack: reports
Fierce Pharma
Sat, 04/2/22 - 11:40 am
Pfizer
employees
cybersecurity
cyberattack
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use
Fierce Pharma
Fri, 04/1/22 - 10:45 am
Merck
Pfizer
vaccines
pneumococcal disease
Vaxneuvance
FDA
pediatric
U.S. approves second Covid-19 booster for people 50 and older
Stat
Tue, 03/29/22 - 11:47 pm
Pfizer
BioNTech
Moderna Therapeutics
FDA
vaccines
boosters
COVID-19
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Fierce Biotech
Tue, 03/29/22 - 10:50 am
Pfizer
ulcerative colitis
etrasimod
Arena Pharmaceuticals
clinical trials
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
Pfizer and BioNTech go to Hollywood with splashy Oscars sponsorship
Fierce Pharma
Mon, 03/28/22 - 07:51 pm
pharma marketing
television ads
BioNTech
Pfizer
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
MedCity News
Mon, 03/28/22 - 10:17 am
FDA
Pfizer
etrasimod
Argenxy
efgartigimod
Aligos Therapeutics
Vallon Pharmaceuticals
Adderall
ORIC Pharmaceuticals
ORIC-101
Neurana Pharmaceuticals
tolperisone
Eli Lilly
sintilimab
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Endpoints
Mon, 03/28/22 - 10:08 am
HHS
Bayh-Dole Act
drug pricing
Pfizer
Gilead Sciences
Xtandi
Paxlovid
Epclusa
Descovy
insulin
Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms
Endpoints
Sun, 03/27/22 - 03:58 pm
COVID-19
Long COVID
GSK
Vir Biotechnology
Humanigen
Pfizer
Roche
Atea Pharmaceuticals
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Motley Fool
Sun, 03/27/22 - 03:55 pm
COVID-19
Sorrento Therapeutics
Moderna Therapeutics
Pfizer
Pfizer grabs another breakthrough tag for RSV shot in older adults
Fierce Biotech
Thu, 03/24/22 - 11:05 am
Pfizer
RSV
vaccines
elderly
breakthrough designation
Pfizer Lining Up New UC Drug, Former Employees Launch Counter Suit
BioSpace
Wed, 03/23/22 - 10:56 pm
Pfizer
ulcerative colitis
Xeljanz
The first big test of Pfizer’s Arena buyout clears a PhIII in bid to catch up to Zeposia
Endpoints
Wed, 03/23/22 - 10:56 am
Pfizer
Zeposia
Bristol Myers Squibb
Arena Pharmaceuticals
etrasimod
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
…
next ›
last »